Towards Whole Health Toxicology: In-Silico Prediction of Diseases Sensitive to Multi-Chemical Exposures.
Olatunbosun ArowoloVictoria SalemmeAlexander SuvorovPublished in: Toxics (2022)
Chemical exposures from diverse sources merge on a limited number of molecular pathways described as toxicity pathways. Changes in the same set of molecular pathways in different cell and tissue types may generate seemingly unrelated health conditions. Today, no approaches are available to predict in an unbiased way sensitivities of different disease states and their combinations to multi-chemical exposures across the exposome. We propose an inductive in-silico workflow where sensitivities of genes to chemical exposures are identified based on the overlap of existing genomic datasets, and data on sensitivities of individual genes is further used to sequentially derive predictions on sensitivities of molecular pathways, disease states, and groups of disease states (syndromes). Our analysis predicts that conditions representing the most significant public health problems are among the most sensitive to cumulative chemical exposures. These conditions include six leading types of cancer in the world (prostatic, breast, stomach, lung, colorectal neoplasms, and hepatocellular carcinoma), obesity, type 2 diabetes, non-alcoholic fatty liver disease, autistic disorder, Alzheimer's disease, hypertension, heart failure, brain and myocardial ischemia, and myocardial infarction. Overall, our predictions suggest that environmental risk factors may be underestimated for the most significant public health problems.
Keyphrases
- public health
- air pollution
- heart failure
- type diabetes
- mental health
- risk factors
- healthcare
- left ventricular
- oxidative stress
- blood pressure
- cardiovascular disease
- stem cells
- squamous cell carcinoma
- single cell
- weight loss
- single molecule
- global health
- transcription factor
- physical activity
- cell therapy
- dna methylation
- cognitive decline
- big data
- copy number
- prostate cancer
- mild cognitive impairment
- health promotion
- genome wide identification
- squamous cell